IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Hovione’s Revenues Rise 11%

11:31 AM MDT | July 14, 2008 | Deepti Ramesh

Active pharmaceutical ingredient (API) manufacturer Hovione (Loures, Portugal) reported sales up 11%, to $103.7 million, for its fiscal year ended March 31. The increase reflects drug approvals by its customers in the innovator as well as generics segments, Hovione says. The company did not report its profits. Hovione says it made significant investments last year in particle design technologies, new production lines, and facility upgrades. The company completed the acquisition last December of a 75% stake in Zhejiang Taizhou Hisyn Pharmaceuticals Co. Ltd...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa